A Double-Blind, Randomized, Placebo-Controlled Trial of NTC-801F in Patients with Symptomatic Bradyarrhythmias (Phase II)

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2026
This article has no abstract
Epistemonikos ID: 33815857acd8dbfb968fc821eb4f0ffdf8f0be4b
First added on: Aug 10, 2026